Heron Therapeutics, Inc.

About Heron Therapeutics, Inc.

Heron Therapeutics is dedicated to improving the lives of patients by developing best-in-class medicines that address unmet medical needs. Their mission focuses on advancing therapeutic standards through innovative science and technologies, delivering impactful therapies for acute care and oncology patients.

Products & Services

SUSTOL(r):FDA-approved subcutaneous injection for the prevention of Chemotherapy-Induced Nausea and Vomiting (CINV).

CINVANTI(r):FDA-approved for CINV, available as a 30-minute IV infusion or a 2-minute IV injection.

ZYNRELEF(r):Approved in the U.S. for postoperative pain management.

Specialties

Acute Care Solutions Oncology Care Solutions Postoperative Pain Management Chemotherapy-Induced Nausea and Vomiting (CINV) Prevention Postoperative Nausea and Vomiting (PONV) Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt Restructuring T: - FT: Debt Restructuring	A: 110000000 MR: - FA: $110.0 million FAN: 110000000	D: 2025-08-08 FD: 2025-08-08	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 30000000 MR: - FA: $30 million FAN: 30000000	D: 2023-07-24 FD: 2023-07-24	4 investors

Debt Restructuring Latest

2025-08-08

$110.0M

1 investor (Pro only)

Private Placement 2023-07-24

$30.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Adam Morgan

Chairman

C

Craig Collard

Chief Executive Officer

S

Sharmila Dissanaike

Director

C

Craig Johnson

Lead Independent Director

M

Michael Kaseta

Director

C

Christian Waage

Director

View 15 more team members with Pro

Unlock Full Team Directory

Recent News